Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 19;14(1):14178.
doi: 10.1038/s41598-024-64228-9.

Mitochondrial division inhibitor (mdivi-1) induces extracellular matrix (ECM)-detachment of viable breast cancer cells by a DRP1-independent mechanism

Affiliations

Mitochondrial division inhibitor (mdivi-1) induces extracellular matrix (ECM)-detachment of viable breast cancer cells by a DRP1-independent mechanism

Eduardo Silva-Pavez et al. Sci Rep. .

Abstract

Increasing evidence supports the hypothesis that cancer progression is under mitochondrial control. Mitochondrial fission plays a pivotal role in the maintenance of cancer cell homeostasis. The inhibition of DRP1, the main regulator of mitochondrial fission, with the mitochondrial division inhibitor (mdivi-1) had been associated with cancer cell sensitivity to chemotherapeutics and decrease proliferation. Here, using breast cancer cells we find that mdivi-1 induces the detachment of the cells, leading to a bulk of floating cells that conserved their viability. Despite a decrease in their proliferative and clonogenic capabilities, these floating cells maintain the capacity to re-adhere upon re-seeding and retain their migratory and invasive potential. Interestingly, the cell detachment induced by mdivi-1 is independent of DRP1 but relies on inhibition of mitochondrial complex I. Furthermore, mdivi-1 induces cell detachment rely on glucose and the pentose phosphate pathway. Our data evidence a novel DRP1-independent effect of mdivi-1 in the attachment of cancer cells. The generation of floating viable cells restricts the use of mdivi-1 as a therapeutic agent and demonstrates that mdivi-1 effect on cancer cells are more complex than anticipated.

Keywords: Cancer; Cell detachment; Mdivi-1; Metabolism; Mitochondrial complex I.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Mdivi-1 induces detachment of viable breast cancer cells. (a) MCF-7 and MDA-MB-231 cells were photographed, and the cellular morphology was documented using a phase-contrast microscope. (b) Schematic representation of the separation of floating and adherent cells into four cell populations: FC, FM, AC, and AM (Created with BioRender.com). (c) MCF-7 and (d) MDA-MB-231 cells were treated with 50 μM mdivi-1 for 24 h. Then, the fraction of viable floating cells relative to the total viable cell population and viable adherent cells was determined. (e), (f) MCF-7 and (e), (g) MDA-MB-231 cells were treated with 50 μM mdivi-1 for 24 h. Next, a clonogenic assay was performed using only the floating cells, FC and FM, isolated from the cell culture medium. FC and FM cells were re-seeding and resuspended in mdivi-1-free cell culture medium. After seven days of growth, the number of colonies were measured using ImageJ software. The scale bar corresponds to 100-μm. Results represent means ± SEM. *p < 0.05; **p < 0.01; ****p < 0.0001.
Figure 2
Figure 2
The floating breast cancer cells induced by mdivi-1 maintain the proliferative and clonogenic potential upon re-seeding. (a), (b) MCF-7 and (c), (d) MDA-MB-231 cells were treated with 50 μM mdivi-1 for 24 h. Floating and adherent cancer cells were collected and re-seeded in mdivi-1-free cell culture medium for 24, 48, 72, and 96 h. Then, a proliferation assay was performed using crystal violet. (e), (f) MCF-7 and (g), (h) MDA-MB-231 cells were treated with 50 μM mdivi-1 for 24 h. Next, four cell populations were collected and re-seeding to carry out the clonogenic assay. After seven days of growth, the number and area of colonies were measured using ImageJ software. (i) MCF-7 and (j) MDA-MB-231 cells were treated with 50 μM mdivi-1 for 24 h. Floating and adherent cells were collected, and then a cell cycle assay analysis was performed. Results represent means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 3
Figure 3
The floating breast cancer cells induced by mdivi-1 maintain the migratory potential upon re-seeding. (a) MDA-MB-231 and (b) MCF-7 cells were treated with 50 μM mdivi-1 for 24 h. Floating and adherent cells were collected, and a transwell migration assay was performed. The four cell populations were photographed, and in vitro transmigration was documented using a phase-contrast microscope. Results represent means ± SEM. **p < 0.01; ns = not significant.
Figure 4
Figure 4
Mdivi-1 induces detachment of breast cancer cells by a DRP1-independent mechanism. (a) DRP1 and β-actin protein levels in WT and DRP1-KO HCT116 cells were determined by western blot (b) these cells were treated with 50 μM mdivi-1 for 24 h. Next, the fraction of viable floating cells relative to the total viable cell population was determined. (c) MCF-7 and MDA-MB-231 cells were treated with 50 μM mdivi-1 for 4 h. Then, a Mito Stress test was performed using a seahorse XFe96 analyzer. (d) MCF-7 and (e) MDA-MB-231 cells were treated with 10 μM rotenone for 24 h, and then, the fraction of viable floating and adherent cells was determined. (f) MCF-7 and MDA-MB-231 cells were treated with 5 μM antimycin-A (AA) and 5 μM oligomycin (Oligo) for 24 h. The fraction of viable floating cells was determined. (g) 143Bwt, 143BΔcytb and (h) Rho-0 cells were treated with 50 μM mdivi-1 for 24 h. Then, the fraction of viable floating and adherent cells was determined. Results represent means ± SEM. *p < 0.05; **p < 0.01; ns = not significant.
Figure 5
Figure 5
Mdivi-1 induces cell detachment in a glucose-dependent manner. (a) MDA-MB-231 cells were treated with 50 μM mdivi-1 and 10 μM rotenone for 24 h. Floating and adherent cells were collected, and a glucose uptake was assessed using the fluorescent substrate 2-NBDG. (b) MCF-7 and MDA-MB-231 cells were treated with 50 μM mdivi-1 for 24 h in a glucose-free cell culture medium. The fraction of viable floating cells was determined. (c) The oxidative subpopulation of MDA-MB-231 cells were treated with 50 μM mdivi-1 for 24 h. Next, the fraction of viable floating and adherent cells was determined. (d) MCF-7 and MDA-MB-231 cells were treated with 50 μM mdivi-1 plus 5 μM BAY-876 for 24 h. Then, the fraction of viable floating cells was determined. (e) MCF-7 and MDA-MB-231 cells were treated with mdivi-1 for 24 h in a glucose-free cell culture medium with 25 mM fructose. The fraction of viable floating cells was determined. (f) MCF-7 and MDA-MB-231 cells were treated with 50 μM mdivi-1 plus 50 μM 6-ANA for 24 h. The fraction of viable floating cells was determined. (g) MCF-7 and MDA-MB-231 cells were treated with 10 μM rotenone plus 50 μM 6-ANA for 24 h. The fraction of viable floating cells was determined. (h) MCF-7 and MDA-MB-231 cells were treated with 50 μM mdivi-1 plus 50 μM 6-ANA for 24 h. Then, a clonogenic assay was performed using only floating cells isolated from the cell culture medium. Next, cells were re-seeding and resuspended in mdivi-1-free cell culture medium. After seven days of growth, the number of colonies were measured using ImageJ software. Results represent means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ns = not significant.
Figure 6
Figure 6
Model of detachment of viable human breast cancer cells induced by mdivi-1. The inhibition of mitochondrial complex I by mdivi-1 triggers the detachment of viable breast cancer cells. These cells maintain their proliferative, migratory, and invasive potential once re-seeding. The effect of mdivi-1 on the cell detachment is independent of DRP1 but dependent on the pentose phosphate pathway (PPP) upon complex I inhibition OM: Outer Mitochondrial Membrane, IS: Intermembrane Space, IM: Inner Mitochondrial Membrane, MM: Mitochondrial Matrix, I: Mitochondrial complex I. (Created with BioRender.com).

Similar articles

Cited by

References

    1. Missiroli S, Perrone M, Genovese I, Pinton P, Giorgi C. Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours. EBioMedicine. 2020;59:102943. doi: 10.1016/j.ebiom.2020.102943. - DOI - PMC - PubMed
    1. Vasan K, Werner M, Chandel NS. Mitochondrial metabolism as a target for cancer therapy. Cell Metab. 2020;32:341–352. doi: 10.1016/j.cmet.2020.06.019. - DOI - PMC - PubMed
    1. Cruz P, et al. Inhibition of InsP3R with Xestospongin B reduces mitochondrial respiration and induces selective cell death in T cell acute lymphoblastic leukemia cells. Int. J. Mol. Sci. 2021;22:651. doi: 10.3390/ijms22020651. - DOI - PMC - PubMed
    1. Janiszewska M, et al. Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev. 2012;26:1926–1944. doi: 10.1101/gad.188292.112. - DOI - PMC - PubMed
    1. Isono T, Chano T, Yonese J, Yuasa T. Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas. Sci. Rep. 2016;6:25669. doi: 10.1038/srep25669. - DOI - PMC - PubMed

MeSH terms

Substances